# Korea Investment & Securities

> Korea Investment & Securities is a VC fund backing Biotechnology. See 82 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Yongdungpo, South Korea
- Total investments: 82
- Last investment: Jul 2026
- Lead investor: 12%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/korea-investment-&-securities-co.-ltd
- Website: https://securities.koreainvestment.com/

Korea Investment & Securities is a financial investment company that offers brokerage, asset management, and investment banking services.

## Contacts

5 contacts available for Korea Investment & Securities. Shizune tracks 1 team members at Korea Investment & Securities. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/korea-investment-securities-d0c5?utm_source=investor_profile

## Round sizes

| Stage | Round size |
| --- | --- |
| Series A | $2.2M–$13M |
| Series B | $1.4M–$25M |
| Series C | $4.5M–$45M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biotechnology | 17 | 21% |
| Health Care | 16 | 20% |
| Software | 14 | 17% |
| Information Technology | 12 | 15% |
| Medical | 11 | 13% |

128 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series B | 22 | 27% |
| Series C | 16 | 20% |
| Series A | 11 | 13% |
| Venture - Series Unknown | 9 | 11% |
| Seed | 5 | 6% |

16 stages tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| South Korea | 72 | 88% |
| United States | 5 | 6% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Jung Il-moon | CEO and President | 1 | https://shizune.co/investors/profile/jung-il-moon |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Flexell Space | Flexell Space engages in space solar cells, focusing on improving cost, delivery, design, and power efficiency. | $20M | Series A | Jul 14, 2026 |  |
| Inocras | Inocras Inc. specializes in whole genome sequencing and analytics, focusing on providing insights for personalized care in cancer and rare diseases. Utilizing artificial intelligence, Inocras aims to revolutionize healthcare by enabling precision medicine. The company offers services to patients, healthcare providers, researchers, and partners,seeking to unlock new possibilities in precision health. With a commitment to innovation, Inocras has introduced products like CancerVision and RareVision, designed to enhance diagnosis and treatment strategies through comprehensive genomic analysis. | $20K | Series B | Jul 01, 2026 |  |
| Coinone | Coinone is the cryptocurrency exchanges. Under the vision to ‘Bring Blockchain into the World,’ they aspires to lead the new world of finance through blockchain technology. They currently operates the third largest exchange. They prioritizes the protection of clients’ assets and is dedicated to providing the most secure investing environment. | $106.4M | Private Equity | May 29, 2026 |  |
| Coinone | Coinone is the cryptocurrency exchanges. Under the vision to ‘Bring Blockchain into the World,’ they aspires to lead the new world of finance through blockchain technology. They currently operates the third largest exchange. They prioritizes the protection of clients’ assets and is dedicated to providing the most secure investing environment. | $53.2M | Secondary Market | May 29, 2026 |  |
| FairSquare Labs | FairSquare Labs offers services for digital asset management and Web 3. Blockchain innovations like the security token mainnet, multi-signature and MPC wallets, de-fi, and dex were created by them. They also mine, stake, trade, and fund crypto venture capital initiatives as well. They believe that the strength of their team places us in a uniqueposition to bridge the gap between traditional and digital assets. |  | Series B | Apr 15, 2026 |  |
| Galux | Galux provides molecular design technology focusing on discovering and developing novel drugs for incurable and rare diseases using its AI-based drug design platform technologies. | $29M | Series B | Feb 09, 2026 |  |
| 1st Biotherapeutics | 1STBIO is dedicated to developing breakthrough therapies with a key value to provide novel medicines to patients. We are focused on discovery and development of innovative first-in-class therapeutic candidates with highly likelihood of clinical success. 1STBIO currently has 24 employees with expertise in biochemistry, medicinal chemistry,pharmacology, and business development. We are working as a core expertise team of drug discovery/development and are rigorously connected to R&D networking of academia, hospitals, industry, CRO’s and investors in Korea, China and US. Our ultimate goal is to use our experience and knowledge to discover and develop effective molecular therapeutics for patients. | $21.9M | Series D | Jan 26, 2026 |  |
| Robocon | Robocon is a machinery manufacturing company that provides robot automation solutions specialised in construction and steel fields. Robocon equipment helps in the field of rebar processing and can be installed on any site, including a portable container module. | $6.9M | Series C | Jan 09, 2026 |  |
| Pharos iBio Co. | Pharos iBio Co. specializing in drug development that develops treatments for intractable diseases. | $12.9M | Post-IPO Debt | Dec 04, 2025 |  |
| Galaxy | Galaxy operates a metaverse platform designed to provide users with infinite content. The company was founded in 2019 and is headquartered in Seoul, Republic of Korea. | $69.9M | Venture - Series Unknown | Nov 03, 2025 |  |

10 of 82 investments shown.

## Co-investors
- [Industrial Bank of Korea](https://shizune.co/investors/profile/industrial-bank-of-korea) — VC Fund, 11 deals together
- [Aju IB Investment](https://shizune.co/investors/profile/aju-ib-investment) — VC Fund, 10 deals together
- [Korea Development Bank](https://shizune.co/investors/profile/korean-development-bank) — VC Fund, 9 deals together
- [Atinum Partners](https://shizune.co/investors/profile/atinum-partners) — VC Fund, 8 deals together
- [DSC Investment](https://shizune.co/investors/profile/dsc-investment) — VC Fund, 8 deals together
- [Korea Investment Partners](https://shizune.co/investors/profile/korea-investment-partners) — VC Fund, 8 deals together

## Similar investors

### Similar industry
- [Unilever Ventures](https://shizune.co/investors/profile/unilever-ventures) — VC Fund
- [Fab Co-Creation Studio Ventures](https://shizune.co/investors/profile/fab-co-creation-studio-ventures) — VC Fund
- [Flybridge](https://shizune.co/investors/profile/flybridge-capital) — VC Fund

### Similar stage
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund
- [FJ Labs](https://shizune.co/investors/profile/fj-labs) — VC Fund

### Similar country
- [Strong Ventures](https://shizune.co/investors/profile/strong-ventures) — VC Fund
- [Korea Credit Guarantee Fund](https://shizune.co/investors/profile/korea-credit-guarantee-fund) — VC Fund
- [Kakao Ventures](https://shizune.co/investors/profile/kakao-ventures) — VC Fund

## Featured in investor lists
- [Manufacturing Investors in South Korea](https://shizune.co/investors/manufacturing-investors-south-korea)
- [Manufacturing VC Funds in South Korea](https://shizune.co/investors/manufacturing-vc-funds-south-korea)
- [Marketplace Investors in South Korea](https://shizune.co/investors/marketplace-investors-south-korea)
- [Marketplace VC Funds in South Korea](https://shizune.co/investors/marketplace-vc-funds-south-korea)
- [Consumer Investors in South Korea](https://shizune.co/investors/consumer-investors-south-korea)
- [Consumer VC Funds in South Korea](https://shizune.co/investors/consumer-vc-funds-south-korea)

## FAQ

### What does Korea Investment & Securities invest in?

Korea Investment & Securities invests primarily in Biotechnology, Health Care and Software startups, most often at Series B and Series C stage. Most of the 82 investments tracked by Shizune back companies in South Korea. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is Korea Investment & Securities's check size?

Korea Investment & Securities typically joins rounds of $2.2M–$13M at Series A, $1.4M–$25M at Series B and $4.5M–$45M at Series C. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Korea Investment & Securities participates in.

### How do I contact Korea Investment & Securities?

Public channels for Korea Investment & Securities include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Korea Investment & Securities?

The team at Korea Investment & Securities includes Jung Il-moon (CEO and President). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co